We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Dr. Douglas McCloskey

Dr. Douglas McCloskey

Independent Consultant

Douglas McCloskey obtained his PhD in 2017 in bioengineering in the lab of Bernhard O. Palsson at the University of California, San Diego. During his studies, he was awarded the prestigious Siebel’s Scholars Foundation grant. Douglas McCloskey was a group leader at the NNF Center for Biosustainability (CfB) at the Technical University of Denmark from 2018 to 2021. At the CfB, he led a group of automation engineers, software engineers, and analytical chemists to develop Big –Omics data generation workflows and led a group of PhDs and Postdocs to develop advanced machine learning and biochemical modeling algorithms to learn from Big –Omics data. Douglas McCloskey was most Chief Scientific Officer and co-founder at AliveX Biotech from 2021 to 2022. At AliveX Biotech, he led the development of an advanced AI and systems biology platform for the identification of biomarkers and drug targets in cancer, autoimmunity, and neurology. Douglas McCloskey currently consults with various enterprises on the adoption and optimization of digitized and automated workflows using robotics and data science in biotechnology, agriculture, and precision medicine.

Got a question for Dr. Douglas McCloskey?

Get in touch using the contact form linked here and we’ll get back to you shortly